AstraZeneca Pharma India on Wednesday said Gagandeep Singh Bedi has resigned from the post of managing director

AstraZeneca Pharma India’s MD resigns; appoints Sanjeev Panchal for 3 years

The drug firm said it has approved the appointment of Sanjeev Panchal as its managing director for a period of three years

AstraZeneca Pharma India’s Managing Director Resigns; Appoints Sanjeev Panchal

The drug firm said it has approved the appointment of Sanjeev Panchal as its managing director for a period of three years.

AstraZeneca Pharma India Appoints Sanjeev Panchal As Managing Director

Panchal had joined AstraZeneca Pharma in February 2003 as Brand Associate and progressed through several positions in India, Indonesia, Asia Pacific and the international region, based in Singapore and the United Kingdom (UK), it said.

AstraZeneca Pharma India’s managing director resigns; appoints Sanjeev Panchal

The drug maker has received an import and market permission in Form CT-20 (subsequent new drug approval) from the Central Drugs Standard Control Organisation for Dapagliflozin tablets of 10 mg.

AstraZeneca Pharma gets CDSCO nod for Dapagliflozin tablets

Stocks to watch before going into trade today.

Stocks To Watch: HCL Tech, Wipro, AstraZeneca Pharma, Infosys, L&T Finance, TCS, Delta Corp, RIL, M&M

Astrazeneca Pharma India Ltd witnessed volume of 67221 shares by 14:14 IST on NSE, a 11.45 times surge over two-week average daily volume of 5870 shares

Volumes jump at Astrazeneca Pharma India Ltd counter

Stocks in news: Paytm, AstraZeneca Pharma, Adani Power, L&T, JSW Steel and more

Stocks in news: Paytm, Adani Power, L&T, JSW Steel and more

Larsen & Toubro (L&T): L&T announced the commissioning of a Green Hydrogen Plant at its AM Naik Heavy Engineering Complex in Hazira, Gujarat. The production of Green Hydrogen based on an alkaline electrolysis process has begun. The plant will

L&T, Wockhardt, AstraZeneca Pharma to be watched

Stocks to Watch: Check out the companies making headlines before the opening bell.

Stocks to Watch Today | JSW Steel, AstraZeneca Pharma, Tejas Networks, and others in news today

AstraZeneca Pharma India Ltd., a mid-cap company with a market cap of Rs. 6,822 crore, has declared dividend for the fiscal year 2021–2022

This Pharma Company Declares 400% Final Dividend, Finalises Record Date

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

AstraZeneca Pharma India Limited is a biopharmaceutical company engaged in the discovery, development and commercialization of medicines for core areas of healthcare.